SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy
Abstract
Authors
H. Wheat A. Hatswell P. Christopoulos S. Ekman F. Guisier E. Hook H. Vioix